Surgical decisions made by 158 women with hereditary breast cancer aged <50 years

被引:35
|
作者
Evans, DGR
Lalloo, F
Hopwood, P
Maurice, A
Baildam, A
Brain, A
Barr, L
Howell, A
机构
[1] St Marys Hosp, Acad Unit Med Genet, Manchester M13 0JH, Lancs, England
[2] St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England
[3] S Manchester Univ Hosp Trust, Withington Hosp, Nightingale Ctr, Breast Canc Family Hist Clin, Manchester, Lancs, England
[4] Christie Hosp, Dept Psychol Med, Manchester M20 9BX, Lancs, England
[5] Christie Hosp, Dept Plast Surg, Manchester M20 9BX, Lancs, England
[6] S Manchester Univ Hosp Trust, Dept Surg, Manchester, Lancs, England
[7] Christie Hosp, Dept Med Oncol, Manchester, Lancs, England
来源
EJSO | 2005年 / 31卷 / 10期
关键词
BRCA1; BRCA2; risk-reducing mastectomy; contralateral;
D O I
10.1016/j.ejso.2005.05.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To establish the uptake of contralateral risk reducing mastectomy in women informed of their risks and options at time of diagnosis of their primary unilateral breast cancer. Methods: We have assessed the surgical choices of 70 women diagnosed with breast cancer <50 years as part of a family history surveillance program and fully informed about their contralateral. risks and surgical options. We have compared this to women from other surgical clinics who were subsequently found to harbour a pathogenic BRCA1/2 mutation. Results: Sixty-five percent (13/20) of BRCA1/2 mutation carriers and 59% (n=20/34) of those at the highest level of risk pre-diagnosis (33+% lifetime risk) opted for contra-lateral mastectomy in the study sample. In contrast only 10% (n=9/88) women identified as mutation carriers from other clinics opted for such surgery. Conclusions: We would suggest that women with a significant family history and therefore a high contra-lateral breast cancer risk, should have these risks and management options discussed at the time of diagnosis of breast cancer. (C) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1112 / 1118
页数:7
相关论文
共 50 条
  • [41] Management of Early Invasive Breast Cancer in Very Young Women (&lt; 35 years)
    Hartmann, Steffi
    Reimer, Toralf
    Gerber, Bernd
    CLINICAL BREAST CANCER, 2011, 11 (04) : 196 - 203
  • [42] Factors Noted to Affect Breast Cancer Treatment Decisions of Women Aged 80 and Older
    Schonberg, Mara A.
    Silliman, Rebecca A.
    McCarthy, Ellen P.
    Marcantonio, Edward R.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2012, 60 (03) : 538 - 544
  • [43] Breast cancer characteristics among women with hereditary breast cancer
    Shah, Tiana
    Venton, Lindsay
    Tezak, Ann
    Weidner, Anne
    Pal, Tuya
    Reid, Sonya
    GENETICS IN MEDICINE, 2022, 24 (03) : S38 - S38
  • [44] Perinatal outcome of women aged 50 years and above
    Pariente, Gali
    Wainstock, Tamar
    Sheiner, Eyal
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 220 (01) : S123 - S124
  • [45] Pregnancy complications in women aged 50 years and older
    Grotegut, Chad
    Chisholm, Christian
    Heine, R. Phillips
    Brown, Haywood
    James, Andra
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 208 (01) : S295 - S295
  • [46] Lack of local surgical treatment strongly decreases prognosis of non-metastatic breast cancer women &lt; 65 years.
    Vlastos, G
    Fioretta, G
    Verkooijen, H
    Schubert, H
    Kurtz, I
    Schaefer, P
    Sappino, P
    Bouchardy, C
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S109 - S109
  • [47] Perinatal Outcomes of Women Aged 50 Years and Above
    Maoz-Halevy, Erez
    Pariente, Gali
    Sheiner, Eyal
    Wainstock, Tamar
    AMERICAN JOURNAL OF PERINATOLOGY, 2020, 37 (01) : 79 - 85
  • [48] Evaluating a DVD promoting breast cancer awareness among black women aged 25-50 years in East London
    Greenhough, Beth
    Dembinsky, Melanie
    Dyck, Isabel
    Brown, Tim
    Robson, John
    Homer, Kate
    Sajani, Cynthia
    Carter, Lucy
    Duffy, Stephen W.
    Ornstein, Mark
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2016, 70 (07) : 678 - 682
  • [49] Symptomatic Breast Cancer Diagnosis and Multimodal Management in Women Aged 40 to 50 Years; Consequences of Current Mammographic Screening Programs
    Joyce, Kenneth M.
    McInerney, Niall M.
    Waters, Peadar S.
    Sweeney, Karl J.
    Barry, Kevin
    Kerin, Michael J.
    CLINICAL BREAST CANCER, 2015, 15 (02) : E125 - E130
  • [50] Breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the Gail model
    Tess V. Clendenen
    Wenzhen Ge
    Karen L. Koenig
    Yelena Afanasyeva
    Claudia Agnoli
    Louise A. Brinton
    Farbod Darvishian
    Joanne F. Dorgan
    A. Heather Eliassen
    Roni T. Falk
    Göran Hallmans
    Susan E. Hankinson
    Judith Hoffman-Bolton
    Timothy J. Key
    Vittorio Krogh
    Hazel B. Nichols
    Dale P. Sandler
    Minouk J. Schoemaker
    Patrick M. Sluss
    Malin Sund
    Anthony J. Swerdlow
    Kala Visvanathan
    Anne Zeleniuch-Jacquotte
    Mengling Liu
    Breast Cancer Research, 21